Activation of CD8(+) T Cell Responses after Melanoma Antigen Targeting to CD169(+) Antigen Presenting Cells in Mice and Humans

The lack of tumor-reactive T cells is one reason why immune checkpoint inhibitor therapies still fail in a significant proportion of melanoma patients. A vaccination that induces melanoma-specific T cells could potentially enhance the efficacy of immune checkpoint inhibitors. Here, we describe a vac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: van Dinther, Dieke, Lopez Venegas, Miguel, Veninga, Henrike, Olesek, Katarzyna, Hoogterp, Leoni, Revet, Mirjam, Ambrosini, Martino, Kalay, Hakan, Stöckl, Johannes, van Kooyk, Yvette, den Haan, Joke M. M.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6406251/
https://ncbi.nlm.nih.gov/pubmed/30764534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11020183
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados